Quantcast

Avantium Launches the Crystalline, a New Parallel System for Crystallization Research

January 22, 2009

AMSTERDAM, January 22 /PRNewswire/ — Avantium Technologies announces the
launch of a new system to study crystallization processes for the
pharmaceutical industry. The system will be marketed under the name
Crystalline.

The Crystalline has been designed to address the need in the pharma
industry to learn as much as possible about a drug candidate early in the
development cycle.

“Avantium is proud to launch its next system in crystallization research.
The Crystalline follows the success of our Crystal16TM, that is used by all
Top 20 pharma companies”, commented Tom van Aken, CEO of Avantium. “We are
excited about the positive feedback of our customers to the new features and
advanced analytics of our new Crystalline.”

The Crystalline enables easy access for scientists to valuable
information on drug candidates, when only a limited amount of sample is
available. Bench chemists can use in situ analytics, on a milliliter scale:
visualization through the vial (on-board camera’s and particle analysis
software) and real time Raman spectroscopy.

Crystalline is a small volume parallel crystallizer with overhead
stirring and refluxing capabilities. The system and software have been
designed by scientists who perform crystallization experiments on a daily
basis, making it easy to program and operate.

The system can be customized, combining turbidity information with a
parallel particle viewer or with real time Raman capabilities, shedding light
on chemical reactions, crystallization processes, polymorph conversions, salt
or co-crystal formation.

About Avantium

Avantium is a leading technology company in the area of advanced
high-throughput R&D operating in the energy, chemicals and pharmaceutical
industries. The company develops products and processes in the area of
biofuels, bio-based chemicals and novel crystal forms of existing drugs by
applying its proprietary, high-throughput R&D technology.

Avantium has demonstrated the potential of this technology by providing
R&D services and tools to more than 70 companies worldwide. Avantium’s
customer base includes many of the world’s largest energy, chemicals and
pharmaceutical companies, such as BP, Shell, Sasol, Pfizer and GSK. Avantium
has approximately 140 employees; its offices and head quarters are based in
Amsterdam, the Netherlands.

http://www.avantium.com/crystalline

SOURCE Avantium Technologies B.V.


Source: newswire



comments powered by Disqus